Glutamic acid decarboxylase autoantibodies (GAD-Ab) in three patients with cerebellar ataxia, late onset insulin-dependent diabetes mellitus (IDDM), and polyendocrine autoimmunity

被引：0
|
作者：
Saiz, A
Arpa, J
Sagasta, A
Casamitjana, R
Zarranz, JJ
Tolosa, E
Graus, F
机构：
来源：
NEUROLOGY | 1997年 / 48卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：56003 / 56003
页数：1
相关论文
共 50 条
  • [21] Transgenic plants expressing human glutamic acid decarboxylase (GAD65), a major autoantigen in insulin-dependent diabetes mellitus
    Porceddu, A
    Falorni, A
    Ferradini, N
    Cosentino, A
    Calcinaro, F
    Faleri, C
    Cresti, M
    Lorenzetti, F
    Brunetti, P
    Pezzotti, M
    MOLECULAR BREEDING, 1999, 5 (06) : 553 - 560
  • [22] Transgenic plants expressing human glutamic acid decarboxylase (GAD65), a major autoantigen in insulin-dependent diabetes mellitus
    Andrea Porceddu
    Alberto Falorni
    Nicoletta Ferradini
    Anna Cosentino
    Filippo Calcinaro
    Claudia Faleri
    Mauro Cresti
    Franco Lorenzetti
    Paolo Brunetti
    Mario Pezzotti
    Molecular Breeding, 1999, 5 : 553 - 560
  • [23] Cerebellar ataxia associated with glutamic acid decarboxylase 65 autoantibodies (GAD65-ab). Long-term impact of immunotherapy
    Arino, H.
    Arribas-Gresa, N.
    Martinez-Hernandez, E.
    Llufriu, S.
    Blanco, Y.
    Dalmau, J.
    Saiz, A.
    Graus, F.
    JOURNAL OF NEUROLOGY, 2014, 261 : S51 - S52
  • [24] Cerebellar ataxia associated with glutamic acid decarboxylase 65 autoantibodies (GAD65-ab). Long-term impact of immunotherapy
    Arino, H.
    Arribas-Gresa, N.
    Martinez-Hernandez, E.
    Llufriu, S.
    Blanco, Y.
    Dalmau, J.
    Saiz, A.
    Graus, F.
    EUROPEAN JOURNAL OF NEUROLOGY, 2014, 21 : 69 - 69
  • [25] Epilepsy in patients with insulin-dependent diabetes and relation to glutamic acid decarboxylase 65
    Mahmoud, Adel A.
    Abdelmagid, Tayseer
    AlGhofely, Mohammed
    Hamed, Ahmed M.
    Al Sharif, Roaa
    NEUROSCIENCES, 2020, 25 (03) : 200 - 204
  • [26] AUTOANTIBODIES TO GLUTAMIC-ACID DECARBOXYLASE (GAD) DETECTED BY AN IMMUNOTRAPPING ENZYME-ACTIVITY ASSAY - RELATION TO INSULIN-DEPENDENT DIABETES-MELLITUS AND ISLET CELL ANTIBODIES
    MARTINO, GV
    TAPPAZ, ML
    BRAGHI, S
    DOZIO, N
    CANAL, N
    POZZA, G
    BOTTAZZO, GF
    GRIMALDI, LME
    BOSI, E
    JOURNAL OF AUTOIMMUNITY, 1991, 4 (06) : 915 - 923
  • [27] GLUTAMIC-ACID DECARBOXYLASE (GAD) AUTOANTIBODIES ARE ADDITIONAL PREDICTIVE MARKERS OF TYPE-1 (INSULIN-DEPENDENT) DIABETES-MELLITUS IN HIGH-RISK INDIVIDUALS
    THIVOLET, C
    TAPPAZ, M
    DURAND, A
    PETERSEN, J
    STEFANUTTI, A
    CHATELAIN, P
    VIALETTES, B
    SCHERBAUM, W
    ORGIAZZI, J
    DIABETOLOGIA, 1992, 35 (06) : 570 - 576
  • [28] ANTIBODIES TO GLUTAMIC-ACID DECARBOXYLASE AS PREDICTORS OF INSULIN-DEPENDENT DIABETES-MELLITUS BEFORE CLINICAL ONSET OF DISEASE
    TUOMILEHTO, J
    ZIMMET, P
    MACKAY, IR
    KOSKELA, P
    VIDGREN, G
    TOIVANEN, L
    TUOMILEHTOWOLF, E
    KOHTAMAKI, K
    STENGARD, J
    ROWLEY, MJ
    LANCET, 1994, 343 (8910): : 1383 - 1385
  • [29] HLA class II is associated with the frequency of glutamic acid decarboxylase M, 65 000 autoantibodies in Japanese patients with insulin-dependent diabetes mellitus
    Kasuga, A
    Falorni, A
    Maruyama, T
    Ozawa, Y
    Grubin, CE
    Matsubara, K
    Takei, I
    Saruta, T
    Scheynius, A
    Lernmark, A
    ACTA DIABETOLOGICA, 1996, 33 (02) : 108 - 113
  • [30] ANTIBODIES TO GLUTAMIC-ACID DECARBOXYLASE AS PREDICTORS OF INSULIN-DEPENDENT DIABETES-MELLITUS - REPLY
    TUOMILEHTO, J
    TUOMILEHTOWOLF, E
    ZIMMET, P
    MACKAY, I
    ROWLEY, M
    LANCET, 1994, 344 (8917): : 266 - 267
12345